|
|
Article: Global Commercialization of Applied Biosystems 3500 Series Genetic Analyzers Sets New Standards for Throughput, Data Quality and Ease-of-Use.
- Article from:
- Cancer Weekly
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Applied Biosystems, part of Life Technologies Corporation (NASDAQ:LIFE), announced the global commercial availability of a new capillary electrophoresis (CE) sequencing system. The 3500 Series Genetic Analyzer builds on Applied Biosystems' industry-leading CE sequencing systems, with state-of-the-art advancements, setting significant new standards for throughput, data quality and ease of use. The 3500 Series Genetic Analyzer is for research use only not intended for therapeutic or diagnostic use (see also Life Technologies Corporation).
Since May 2009, more than 10 research institutions have been participating in an early evaluation of the technology with primary ...